Full-length myocilin protein is purified from mammalian cells as a dimer
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Protein Expression and Purification
- Vol. 147, 38-48
Abstract
No abstract availableKeywords
Funding Information
- Novartis Institutes for BioMedical Research, Cambridge (MA 02139)
This publication has 29 references indexed in Scilit:
- Higher Prevalence of Myocilin Mutations in Advanced Glaucoma in Comparison with Less Advanced Disease in an Australasian Disease RegistryOphthalmology, 2013
- Keeping an Eye on Myocilin: A Complex Molecule Associated with Primary Open-Angle Glaucoma SusceptibilityMolecules, 2011
- Protein structure homology modeling using SWISS-MODEL workspaceNature Protocols, 2008
- In-gel digestion for mass spectrometric characterization of proteins and proteomesNature Protocols, 2006
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- Reversal of mutant myocilin non-secretion and cell killing: implications for glaucomaHuman Molecular Genetics, 2004
- The genetics of open-angle glaucoma: The story of GLC1A and myocilinEye, 2000
- Gene Structure and Properties of TIGR, an Olfactomedin-related Glycoprotein Cloned from Glucocorticoid-induced Trabecular Meshwork CellsJournal of Biological Chemistry, 1998
- Cellular Pharmacology and molecular Biology of the Trabecular Meshwork Inducible glucocorticoid Response Gene ProductOphthalmologica, 1997
- Preliminary characterization of a transformed cell strain derived from human trabecular meshworkCurrent Eye Research, 1994